Hannah Joseph Hospital to Open INR 42 Cr IPO for Oncology &Tertiary Care Expansion

The IPO proceeds are expected to be primarily utilized for establishing a Radiation Oncology Centre, a move that would add cancer care to the hospital’s existing clinical portfolio and corporate purposes.

Hannah Joseph Hospital, a Madurai-based multi-speciality hospital, has announced that its initial Public Offering will open on January 22, 2026, aiming to raise INR 42 Cr through a fresh issue of 60 lakh equity shares to support the expansion of advanced hospital services and infrastructure.

Priced between ₹67 and ₹70 per share, the IPO is positioned to fund the hospital’s next phase of clinical and capacity expansion.

The hospital has steadily evolved since its founding in 2008, transitioning from a single-speciality setup into a multi-speciality tertiary care hospital serving South Tamil Nadu, housing approximately 150 beds and advanced medical infrastructure.

Dr Moses Joseph Arunkumar, Chairman and Managing Director of Hannah Joseph Hospital, said, "Since its inception, remained committed to delivering advanced, ethical, and patient-centric healthcare services. Our evolution from a single-speciality focus to a multi-speciality tertiary care hospital reflects our continuous investments in clinical excellence, technology, and skilled medical professionals. Being a regional referral centre for complex neurological, neurosurgical, cardiac, and trauma care, we have consistently strengthened our infrastructure and clinical capabilities to meet the growing healthcare needs of South Tamil Nadu.

The proposed IPO is expected to support the hospital’s planned capacity and service expansion initiatives, enabling it to strengthen its clinical offerings and deliver more integrated, end-to-end care. These initiatives are aimed at enhancing patient convenience and treatment outcomes while broadening the Company's ability to serve complex medical needs under a single platform. The expansion is also expected to drive incremental inpatient and outpatient volumes and support sustainable growth in revenues over the medium to long term."

The IPO proceeds are expected to be primarily utilized for establishing a Radiation Oncology Centre, a move that would add cancer care to the hospital’s existing clinical portfolio and enable more comprehensive, end-to-end treatment under one roof. The remaining funds will be directed toward general corporate purposes.

Sunil Kumar Manocha, Founder and Director of Capital Square Advisors, said, "Hannah Joseph Hospital operates a tertiary care facility in its core market with a focused presence across neurosciences, cardiology, trauma, and critical care.”

“Supported by accredited operations and participation in government insurance schemes, the hospital is positioned to deploy incremental capital towards capacity enhancement and service integration initiatives. These initiatives are expected to expand clinical offerings, improve patient throughput and case mix, and support growth in inpatient and outpatient revenues," he added.

The anchor book for the issue opens on January 21, while the public issue closes on January 27, 2026. Capital Square Advisors Private Limited is acting as the Book Running Lead Manager, and Bigshare Services Private Limited has been appointed as the registrar.

Stay tuned for more such updates on Digital Health News